Nvidia reported $96.2 billion in second-quarter revenue and projected 70% growth for fiscal 2028, boosting its stock in after-hours trading. Meanwhile, Meta agreed to a settlement of up to $18 billion with U.S. states over child safety allegations. Additionally, French quantum computing firm Pasqal completed a $2 billion SPAC merger on the Nasdaq.
01Company specific
OpenAI End Partnership with Cursor
Relying on change-of-control clauses to sever supply agreements with acquirers exposes AI wrappers to existential counterparty risk when direct competitors buy their underlying distribution channels.
OpenAI will cut off Cursor's access to its AI models on November 12, 2026, following SpaceX's $60 billion acquisition of Cursor parent Anysphere. OpenAI cited a lack of trust in Elon Musk-owned companies adhering to its terms of service, pointing to past contract breaches by X and admissions from Musk that xAI violated terms by training Grok on OpenAI outputs. The termination strips the popular coding assistant of frontier models like GPT-5.6 Luna, Sol, and Terra, leaving it to lean on Anthropic and its in-house Composer model. SpaceX completed the all-stock acquisition in August, folding Cursor into its SpaceXAI division under CEO Michael Truell. Developers relying on Cursor must transition away from OpenAI models ahead of the November deadline.
Honda and Nissan Near Deal for Joint Vehicle Software Development
Shared operating system development lets automakers divide fixed software overhead without the governance friction or equity dilution of a full corporate merger.
Honda Motor and Nissan Motor are expected to agree as soon as Monday to jointly develop a shared operating system and onboard computer for new vehicles arriving as early as 2029. The collaboration spreads the heavy engineering costs of software-defined cars across both balance sheets while leaving each automaker entirely independent. This arrangement follows the collapse of merger talks in February 2025, when a planned $60 billion combination fell apart after Nissan balked at becoming a subsidiary of Honda. Nissan enters the partnership following a swing to a ¥3.76 billion quarterly profit in April-to-June, recovering from a ¥533.1 billion loss in the prior fiscal year. Both companies have previously worked with external suppliers including Nvidia and Wayve, and the new in-house platform aims to provide a unified foundation beneath those separate systems. Honda stated that no final deal has been decided, while Nissan noted it was exploring various possibilities.
Nvidia Beats Q2 Earnings Estimates and Issues Strong Revenue Guidance
A contraction in gross margin despite surging data center demand reveals that advanced packaging costs and supply constraints are squeezing profitability for primary chip producers.
Nvidia reported fiscal second-quarter revenue of $96.2 billion, doubling its top line year-over-year and beating Wall Street estimates of $92.2 billion. Adjusted earnings per share came in at $2.22, topping expectations of $2.09. Driven by persistent demand for artificial intelligence hardware, the chipmaker guided for third-quarter revenue of $108 billion. In a rare move, management also issued a fiscal 2028 outlook projecting 70% annual sales growth. CEO Jensen Huang stated that supply chain constraints prevent the company from fulfilling all incoming orders, leaving output capped at that 70% expansion rate. The blowout numbers sent the stock up 7.63% in after-hours trading and lifted broader technology futures.
FDA Seeks Public Input on Regulating Generative AI Medical Devices
Shift-planning for generative health tools toward clinician-style competency evaluations creates pre-market compliance hurdles that favor deep-pocketed platform incumbents over standalone point-solution startups.
The U.S. Food and Drug Administration has opened a public consultation on regulating medical devices powered by generative artificial intelligence, setting an October 19, 2026 comment deadline. While the agency has authorized over 1,000 conventional AI medical devices, generative systems introduce open-ended outputs, variable responses, and reliance on third-party foundation models that current regulatory frameworks do not fully address. The discussion paper outlines a proposed two-axis risk framework evaluating software function and the severity of potential harm from incorrect outputs, ranging from informational support to autonomous action. To address these challenges, the FDA is exploring a competency-based evaluation model inspired by human clinician credentialing, incorporating non-clinical benchmarking and clinical confirmation studies before market entry. The consultation does not establish binding policy or immediate new evidence requirements, but serves to gather stakeholder feedback on how to oversee technologies capable of producing hallucinations or variable clinical recommendations.
Brave Browser Launches Integrated Email Alias Support
Privacy features that block ad-matching force consumer tech firms to trade immediate advertising yield for subscription revenue models secured through proprietary cryptographic lock-in.
Brave has rolled out integrated email alias support in desktop version 1.94, allowing users to sign up for online services without exposing their real email addresses. The feature generates disposable forwarding addresses directly from website sign-up forms, routing incoming messages to a primary inbox while blocking server-side ad-matching techniques used by networks like Meta. Free accounts are limited to five aliases during the initial rollout, with a paid premium tier planned for users requiring higher caps. To access the tool, users must create a Brave account secured by the OPAQUE cryptographic protocol, which authenticates logins without transmitting plaintext passwords to server infrastructure. Incoming messages undergo automated spam and virus scanning before server copies are permanently wiped, and local encryption protects any custom notes stored alongside individual aliases.
French Quantum Computer Maker Pasqal Surges in Nasdaq Debut
Sustained capital expenditure for neutral-atom hardware relies on early industrial off-take contracts to de-risk commercialization before quantum error correction achieves full fault tolerance.
French quantum computing maker Pasqal surged 40 percent in its Nasdaq debut on Friday after completing a merger with blank-check company Bleichroeder Acquisition Corp II. The transaction valued the loss-making hardware developer at approximately $2 billion and left it with roughly $360 million in cash to scale manufacturing. Pasqal uses lasers to position and manipulate neutral atoms for quantum processing, distinguishing itself from peers through commercial contracts with clients like Saudi Aramco. The company generated €16.5 million, or $19.15 million, in revenue during 2025 and has deployed seven machines across national supercomputing centers in France, Germany, Italy, and Canada. While competitors like Google and IBM target fault-tolerant systems by the end of the decade, persistent error rates continue to limit large-scale reliability across the sector. The newly public firm plans to direct its cash injection toward expanding its French and Canadian production facilities, which currently possess a combined capacity of up to 13 machines annually.
Meta and US States Discuss Settlement in Youth Social Media Harm Lawsuits
Mid-trial state settlements over youth addiction force social networks to alter core engagement algorithms, directly eroding the daily active user metrics underpinning ad-supported business models.
Meta Platforms agreed to pay up to $18 billion to resolve a sweeping lawsuit brought by a bipartisan group of state attorneys general accusing the tech giant of designing its platforms to addict children. Under the terms of the consent judgment approved by a federal court in Oakland, California, participating states will receive roughly $12.7 billion of that total over a 10-year period. The remaining $5.3 billion is contingent on rival platforms such as Google's YouTube and TikTok accepting comparable obligations and settlement terms. Beyond the financial penalty, Meta must implement new product changes across Facebook and Instagram, including enhanced age-assurance measures, default daily usage limits, and nighttime blocks for teenage accounts. The settlement allows Meta to avoid a potentially lengthy trial that could have exposed more internal documents and left the company exposed to broader legal liabilities.
Strong chip revenues and new quantum listings show deep AI momentum, but massive regulatory settlements and tightening FDA rules threaten margins. How quickly compliance costs will drag on mega-cap tech expansion is unresolved.
This, every morning.
SuMarket writes Technology Sector every morning, along with every other section of the market and the companies and topics you follow. Free to read.